PF-07994525

PF-07994525 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-07994525, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers [Phase 1]